| 000 | 01332 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513161926.0 | ||
| 264 | 0 | _c19990128 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/s0002-9149(98)00732-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorgan, J M | |
| 245 | 0 | 0 |
_aA new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cDec 1998 |
||
| 300 |
_a29U-34U; discussion 39U-41U p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFlushing _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemias _xblood |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNiacin _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 700 | 1 | _aCapuzzi, D M | |
| 700 | 1 | _aGuyton, J R | |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 82 _gno. 12A _gp. 29U-34U; discussion 39U-41U |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(98)00732-2 _zAvailable from publisher's website |
| 999 |
_c9877393 _d9877393 |
||